Gouda, Netherlands

Annieck M Diks

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Annieck M Diks

Introduction

Annieck M Diks is a notable inventor based in Gouda, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and antibodies. His work has implications for therapeutic applications, showcasing the potential of innovative solutions in medicine.

Latest Patents

Annieck M Diks holds a patent for "Polypeptide variants and uses thereof." This patent describes polypeptides and antibodies that feature an Fc region with specific mutations. These mutations enhance the Fc region's functionality, leading to increased complement-dependent cytotoxicity (CDC) activity and agonistic activity. This advancement represents a significant step forward in the development of effective therapeutic agents.

Career Highlights

Throughout his career, Annieck has been associated with Genmab B.V., a leading biotechnology company. His work at Genmab has allowed him to focus on innovative research and development in the field of immunotherapy. His contributions have been instrumental in advancing the company's mission to create differentiated antibody therapeutics.

Collaborations

Annieck M Diks has collaborated with notable colleagues, including Frank Beurskens and Marije Overdijk. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Annieck M Diks exemplifies the spirit of innovation in biotechnology through his patent and work at Genmab B.V. His contributions are paving the way for future advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…